Jun 13, 2025 2:08 AM
BACK TO TOP
KSE100
124,093.12
-259.56
(-0.21%)
ALLSHR
77,106.29
-221.51
(-0.29%)
KSE30
37,536.68
-95.15
(-0.25%)
KMI30
184,370.68
-1061.53
(-0.57%)
BKTI
30,369.22
57.60
(0.19%)
OGTI
27,659.36
-295.77
(-1.06%)
KMIALLSHR
53,011.14
-164.22
(-0.31%)
PSXDIV20
47,084.53
-243.62
(-0.51%)
UPP9
39,865.27
-81.59
(-0.20%)
NITPGI
30,751.76
-74.05
(-0.24%)
NBPPGI
33,161.35
-138.58
(-0.42%)
MZNPI
22,446.52
-215.60
(-0.95%)
JSMFI
35,170.10
61.58
(0.18%)
ACI
20,000.75
17.15
(0.09%)
JSGBKTI
36,657.76
-152.98
(-0.42%)
MII30
16,921.85
-63.44
(-0.37%)
HBLTTI
16,822.06
11-06-2025
6.45
(0.04%)
Abbott Laboratories (Pakistan) Limited
PHARMACEUTICALS
Rs.997.14
-1.10
(-0.11%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, Jun 12, 2025 3:47 PM
REG
FUT
ODL
Open
1,010.00
High
1,034.00
Low
991.00
Volume
18,450
CIRCUIT BREAKER
898.42 — 1,098.06
DAY RANGE
991.00 — 1,034.00
52-WEEK RANGE
650.10 — 1,310.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
998.24
VAR
14.50
HAIRCUT
25.00
P/E Ratio (TTM) **
18.37
1-Year Change *
46.55%
YTD Change *
-19.45%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

KEY PEOPLE
Syed Anis AhmedCEO
Ehsan A. MalikChairperson
Muhammad Usama JamilCompany Secretary
ADDRESS

Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan

WEBSITE

www.pk.abbott

REGISTRAR

FAMCO Share Registration Services (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
97,620,307.14
Shares
97,900,302
Free Float
21,118,519
Free Float
21.57%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2025Transmission of Quarterly Report for the Period Ended March 31, 2025 View   PDF
Apr 28, 2025Financial Results for the Quarter Ended March 31, 2025 View   PDF
Mar 25, 2025Transmission of Annual Report for the Year Ended 31 December 2024 View   PDF
Feb 25, 2025Additional Information to Financial Results for the Year Ended 31st December 2024 View   PDF
Feb 20, 2025Financial Results for the Year Ended December 31st, 2024 View   PDF
Oct 30, 2024Transmission of Quarterly Report for the Period Ended September 30, 2024 View   PDF
Oct 25, 2024Financial Results for the Quarter Ended September 30, 2024 View   PDF
Aug 28, 2024Transmission of Quarterly Report for the Period Ended June 30, 2024 View   PDF
Aug 26, 2024Financial Results for thr Quarter Ended June 30 2024 View   PDF
Apr 30, 2024Transmission of Quarterly Report for the Period Ended March 31, 2024 View   PDF
DateTitleDocument
Apr 23, 2025Certified copy of Resolutions passed at the 76th Annual General Meeting View   PDF
Apr 21, 2025Board Meeting View   PDF
Mar 25, 2025Notice of Annual General Meeting View   PDF
Feb 13, 2025Board Meeting View   PDF
Oct 18, 2024Board Meeting View   PDF
Aug 19, 2024Board Meeting View   PDF
Apr 23, 2024Certified copy of Resolution passed at the 75th Annual General Meeting View   PDF
Apr 18, 2024Board Meeting View   PDF
Apr 8, 2024Addendum to the Notice of 75th Annual General Meeting View   PDF
Mar 29, 2024Notice of Annual General Meeting View   PDF
DateTitleDocument
May 2, 2025Appointment of Director View   PDF
Apr 29, 2025Credit of Final Cash Dividend View   PDF
Feb 3, 2025Resignation of Board Director View   PDF
Dec 17, 2024Presentation of Corporate Briefing Session 2024 View   PDF
Dec 12, 2024Corporate Briefing Session 2024 View   PDF
Apr 15, 2024Publication of Postal Ballot and Provision of Electronic Voting for Voting on Special Business View   PDF
Jan 4, 2024Notice to Shareholders regarding Transfer of Shares Registrar/ Transfer Agent Services (Post Publication) View   PDF
Dec 29, 2023TRANSFER OF SHARES REGISTRAR/ TRANSFER AGENT SERVICES View   PDF
Dec 5, 2023Presentation of Corporate Briefing Session 2023 View   PDF
Dec 1, 2023Notice for Briefing Session View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales68,177,19755,475,27049,257,72242,569,856
Profit after Taxation5,234,233261,7773,004,1865,967,057
EPS53.462.6730.6960.95
Q1 2025Q3 2024Q2 2024Q1 2024
Sales17,346,45117,364,54616,170,60516,028,928
Profit after Taxation1,599,6731,809,143621,3801,518,760
EPS16.3418.486.3515.51
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)28.9521.3629.4937.76
Net Profit Margin (%)7.680.476.1014.02
EPS Growth (%)1,902.25(91.30)(49.65)31.56
PEG0.01(1.89)(0.30)0.37

Payouts

DateFinancial ResultsDetailsBook Closure
February 20, 2025 3:45 PM31/12/2024(YR) 100%(F) (D) 16/04/2025 - 23/04/2025
August 29, 2022 2:59 PM30/06/2022(HYR) 150%(i) (D) 12/09/2022 - 14/09/2022
February 24, 2022 2:57 PM31/12/2021(YR) 200%(F) (D) 14/04/2022 - 21/04/2022
August 27, 2021 11:10 AM30/06/2021(YR) 200%(i) (D) 10/09/2021 - 17/09/2021
February 26, 2021 4:27 PM31/12/2020(YR) 250%(F) (D) 14/04/2021 - 21/04/2021
August 28, 2020 12:14 PM30/06/2020(HYR) 150% (i) (D) 09/09/2020 - 16/09/2020
March 2, 2020 3:11 PM31/12/2019(YR) 75%(F) (D) 20/05/2020 - 27/05/2020
February 21, 2019 3:04 PM31/12/2018(YR) 100%(F) (D) 16/04/2019 - 23/04/2019
August 17, 2018 3:07 PM30/06/2018(HYR) 100% (D) 04/09/2018 - 11/09/2018
February 26, 2018 3:36 PM31/12/2017(YR) 300% (D) 14/04/2018 - 23/04/2018

Financial Reports